Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

42.02
-0.7200-1.68%
Post-market: 41.00-1.0200-2.43%19:30 EDT
Volume:3.82M
Turnover:161.54M
Market Cap:2.45B
PE:13.59
High:43.27
Open:42.57
Low:41.90
Close:42.74
52wk High:43.49
52wk Low:25.52
Shares:58.24M
Float Shares:50.80M
Volume Ratio:3.40
T/O Rate:7.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.45
PE(LYR):15.51

Loading ...

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Jun 24

Harmony Biosciences spotlights Phase 3 HBS-301 narcolepsy, idiopathic hypersomnia studies at SLEEP 2026

Reuters
·
Jun 11

Harmony Biosciences to present six narcolepsy, idiopathic hypersomnia posters at SLEEP 2026 meeting

Reuters
·
Jun 11

Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say. -- Barrons.com

Dow Jones
·
Jun 04

Harmony Biosciences to present at Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 27

Harmony Biosciences CFO Glenn Reicin files initial beneficial ownership statement

Reuters
·
May 19

Harmony Biosciences Shareholders Approve Governance Measures at Meeting

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)

TIPRANKS
·
May 11

Harmony Biosciences Is Maintained at Hold by Truist Securities

Dow Jones
·
May 09

Harmony Biosciences price target raised to $29 from $25 at Truist

TIPRANKS
·
May 08

Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.02B

TIPRANKS
·
May 07

Stock Track | Harmony Biosciences Plunges 5.43% in Pre-Market After Q1 Earnings Miss Estimates

Stock Track
·
May 07

GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 WAKIX Net Revenue Range $1.0B - $1.04B

MT Newswires Live
·
May 07

Earnings Flash (HRMY) Harmony Biosciences Posts Q1 EPS $0.55, vs. FactSet Est of $0.69

MT Newswires Live
·
May 07

Harmony Biosciences Q1 revenue rises less than expected

Reuters
·
May 07

Harmony Biosciences Q1 Adj. EPS $0.55 Misses $0.69 Estimate, Sales $215.400M Miss $225.227M Estimate

Benzinga Earnings
·
May 07

BRIEF-Harmony Biosciences Q1 Net Income USD 32.488 Million

Reuters
·
May 07

Harmony Biosciences: on Track to Achieve >$1 Bln in Narcolepsy Net Sales in 2026

THOMSON REUTERS
·
May 07

Harmony Biosciences Q1 Gross Profit USD 170.875 Million

THOMSON REUTERS
·
May 07